Header cover image

Belgian Healthy high growth potential

Results

1

0 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1 companies

argenx

Market Cap: €40.1b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€647.20

7D

7.5%

1Y

20.6%